mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.1 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.1 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
paclitaxel |
FIMM |
pan-cancer |
AAC |
0.21 |
0.1 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |